27

2021

-

01

Pharmaceutical Friends' Innovative Drug Team - New Medical Engineering Institute Kick-off Meeting

Source:


1
On December 3, 2020, the inaugural meeting of the New Chongqing Medical Engineering Institute was held in Conference Room 1008 of the Yaoyou Pharmaceutical Group's administrative building, attended by Mr. Liu Qiang, Chairman of Yaoyou Pharmaceutical Group, Ms. Zhang Yan, Co-President, and key cadres and management personnel of the New Chongqing Medical Engineering Institute.
At the meeting, the organizational structure and leadership appointments of the New Medical Engineering Institute were officially announced:
Ms. Zhang Yan, Co-President of Yaoyou, was appointed as Executive Director and General Manager, Mr. Lei Huangshu as Chief Scientist, Mr. Cao Yaming as Deputy General Manager in charge of R&D, and Ms. Fu Chencheng as Deputy General Manager in charge of Human Resources and Administration.
Subsequently, Chairman Liu and General Manager Zhang expressed their earnest hopes and specific requirements for the strategic planning and development direction of the New Medical Engineering Institute:
1. The personnel of the New Medical Engineering Institute should inherit and carry forward the professional spirit of excellence and diligent research pursued by the older generation of medical engineers, continuing the glorious history of the medical engineering institute in the pharmaceutical industry.
2. The innovation gene should be deeply embedded in the New Chongqing Medical Engineering Institute, where the first innovative drug of Yaoyou Group will be born, which is also part of the overall strategic planning of Fosun Pharma Group.
3. The newly appointed young cadres should learn the spirit of dedication and practical work from the leaders of the old medical engineering institute, set an example, lead the entire innovative drug team to advance rapidly and surpass peers, and achieve goals as soon as possible.
4. The New Medical Engineering Institute should strengthen close cooperation with domestic universities to attract more outstanding talents with a passion for medicine to join; in the future, the New Medical Engineering Institute will be a high-quality talent team focused on innovative drug R&D.
Finally, the main members of the new management team also expressed their confidence and determination for the future development of the New Medical Engineering Institute.
Currently, the New Chongqing Medical Engineering Institute has officially started operations on January 1, 2021, and we look forward to the company, with everyone's joint efforts, being reborn from the ashes, achieving a phoenix-like rebirth, and reaching new heights.

Key words:

The digital transformation of the pharmaceutical industry is accelerating. How can pharmaceutical companies strategize to achieve sales growth?

In the future digital transformation of the pharmaceutical industry, how should pharmaceutical companies position themselves

2021-04-13

The current status of the development of the pharmaceutical industry in China in 2020.

2019 was an important year for the transformation and key upgrade of the pharmaceutical industry in our country.

2021-04-13

Progress has been made in the research of nano-medicines for pancreatic cancer.

Pancreatic cancer has a high mortality rate, and its fundamental reason for being difficult to treat lies in the fact

2021-04-13

Building a communication platform for government and enterprises to discuss new opportunities for high-quality development in the pharmaceutical industry.

Nanfang Daily News - On April 9, the fifth Cloud Cheng Tian Yu Food and Drug Review and Certification

2021-04-13